Biblio
Export 370 results:
Author Title [ Type
Filters: First Letter Of Last Name is E [Clear All Filters]
“Phytochemicals from Achillea fragrantissima are Modulators of AβPP Metabolism.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1425-1435, 2018.
, “The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.”, J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
, “Plasma Biomarkers of Alzheimer's Disease in African Americans.”, J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
, “Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies.”, J Alzheimers Dis, vol. 66, no. 2, pp. 587-600, 2018.
, “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.
, “Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.”, J Alzheimers Dis, vol. 60, no. 2, pp. 349-358, 2017.
, “Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 691-701, 2017.
, “A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 97-104, 2018.
, “Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.”, J Alzheimers Dis, vol. 55, no. 1, pp. 371-379, 2017.
, “Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1275-1283, 2017.
, “Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1179-1187, 2022.
, “Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1637-1649, 2021.
, “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
, “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
, “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
, “Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.”, J Alzheimers Dis, vol. 92, no. 1, pp. 341-348, 2023.
, “Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1221-1232, 2018.
, “Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1221-1232, 2018.
, “Psychometric Properties of Apathy Scales in Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1065-1082, 2018.
, “Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1419-1428, 2017.
, “Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
, “Quality of Life in Advanced Dementia with Late Onset, Young Onset, and Very Young Onset.”, J Alzheimers Dis, vol. 80, no. 1, pp. 283-297, 2021.
, “Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
,